Maze Therapeutics, Inc.·4

Aug 19, 4:15 PM ET

Exter Neil 4

4 · Maze Therapeutics, Inc. · Filed Aug 19, 2025

Insider Transaction Report

Form 4
Period: 2025-08-17
Exter Neil
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-08-17+16,00016,000 total
    Exercise: $13.35Exp: 2035-08-16Common Stock (16,000 underlying)
Footnotes (1)
  • [F1]The option vested as to 1/16th of the total award on March 3, 2025, and thereafter vested or vests as to an additional 1/16th of the total award on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.

Documents

1 file
  • 4
    form4-08192025_080831.xmlPrimary